Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Accounts Payables (2016 - 2024)

Historic Accounts Payables for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $5.7 million.

  • KalVista Pharmaceuticals' Accounts Payables changed N/A to $5.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.7 million, marking a year-over-year change of. This contributed to the annual value of $9.1 million for FY2024, which is N/A changed from last year.
  • As of Q4 2024, KalVista Pharmaceuticals' Accounts Payables stood at $5.7 million.
  • KalVista Pharmaceuticals' 5-year Accounts Payables high stood at $10.8 million for Q3 2024, and its period low was $641000.0 during Q1 2021.
  • Its 4-year average for Accounts Payables is $4.4 million, with a median of $4.0 million in 2023.
  • In the last 5 years, KalVista Pharmaceuticals' Accounts Payables tumbled by 7827.85% in 2021 and then skyrocketed by 11328.06% in 2024.
  • Over the past 4 years, KalVista Pharmaceuticals' Accounts Payables (Quarter) stood at $2.2 million in 2020, then crashed by 70.5% to $641000.0 in 2021, then skyrocketed by 663.81% to $4.9 million in 2023, then rose by 16.95% to $5.7 million in 2024.
  • Its last three reported values are $5.7 million in Q4 2024, $5.2 million for Q4 2024, and $10.8 million during Q3 2024.